In silico design and analysis of a new hyperglycosylated analog of erythropoietin to improve drug efficacy.

about

In silico design and analysis of a new hyperglycosylated analog of erythropoietin to improve drug efficacy.

Item

http://www.wikidata.org/entity/Q35997019

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

In silico design and analysis ...... etin to improve drug efficacy.

@ast

In silico design and analysis ...... etin to improve drug efficacy.

@en

type

Item

label

In silico design and analysis ...... etin to improve drug efficacy.

@ast

In silico design and analysis ...... etin to improve drug efficacy.

@en

prefLabel

In silico design and analysis ...... etin to improve drug efficacy.

@ast

In silico design and analysis ...... etin to improve drug efficacy.

@en

P1476

In silico design and analysis ...... etin to improve drug efficacy.

@en

P2093

Anvarsadat Kianmehr

http://www.w3.org/2001/XMLSchema#string

Eskandar Omidinia

http://www.w3.org/2001/XMLSchema#string

Hamid Shahbaz Mohammadi

http://www.w3.org/2001/XMLSchema#string

Mohammad Ali Shokrgozar

http://www.w3.org/2001/XMLSchema#string

P2860

GlyProt: in silico glycosylation of proteins

Developing a dynamic pharmacophore model for HIV-1 integrase.

Identification of nonpeptidic urotensin II receptor antagonists by virtual screening based on a pharmacophore model derived from structure-activity relationships and nuclear magnetic resonance studies on urotensin II.

Glycosylation of therapeutic proteins: an effective strategy to optimize efficacy

In silico theoretical molecular modeling for Alzheimer's disease: the nicotine-curcumin paradigm in neuroprotection and neurotherapy.

Bioinformatics and molecular modeling in glycobiology.

The amino acid at the X position of an Asn-X-Ser sequon is an important determinant of N-linked core-glycosylation efficiency.

Enhancement of therapeutic protein in vivo activities through glycoengineering.

Generation of predictive pharmacophore models for CCR5 antagonists: study with piperidine- and piperazine-based compounds as a new class of HIV-1 entry inhibitors.

NetCGlyc 1.0: prediction of mammalian C-mannosylation sites.

P304

142

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4103/2277-9175.161548

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-07-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26322290

http://www.w3.org/2001/XMLSchema#string

P921

Erythropoietin

P932

4549927

http://www.w3.org/2001/XMLSchema#string